Drug Shortage Report for CEFTAZIDIME FOR INJECTION BP
| Report ID | 8810 |
| Drug Identification Number | 02437864 |
| Brand name | CEFTAZIDIME FOR INJECTION BP |
| Common or Proper name | CEFTAZIDIME FOR INJECTION BP |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CEFTAZIDIME |
| Strength(s) | 6G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 1 VIAL |
| ATC code | J01DD |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2017-05-01 |
| Estimated end date | 2017-05-19 |
| Actual end date | 2017-05-24 |
| Shortage status | Resolved |
| Updated date | 2017-05-25 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-05-03 | English | Compare |
| v2 | 2017-05-03 | French | Compare |
| v3 | 2017-05-24 | English | Compare |
| v4 | 2017-05-24 | French | Compare |
| v5 | 2017-05-24 | English | Compare |
| v6 | 2017-05-25 | English | Compare |
Showing 1 to 6 of 6